Condition: Diabetic Foot Ulcer · Sponsor: NuScience Medical Biologics, LLC
This is a randomized controlled crossover trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in treating diabetic foot ulcers.
This description comes directly from the study's public registry record.
Angelina Ferguson, DNP · (985) 629-4013 · info@sygnola.com
Sarah Moore, MBE · (985) 629-4013 · info@sygnola.com
Always discuss trial participation with your own doctor first.
| MedCentris of Alexandria | Alexandria, Louisiana, United States | Recruiting |
| MedCentris of Franklinton | Franklinton, Louisiana, United States | Completed |
| MedCentris of Hammond | Hammond, Louisiana, United States | Recruiting |
| MedCentris of Minden | Minden, Louisiana, United States | Recruiting |
| MedCentris of Monroe | Monroe, Louisiana, United States | Completed |
| MedCentris of Natchez | Natchez, Mississippi, United States | Completed |
| MedCentris of Picayune | Picayune, Mississippi, United States | Recruiting |
| Pace Foot and Ankle Center | Bryn Mawr, Pennsylvania, United States | Completed |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06938685